SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-008510
Filing Date
2023-05-08
Accepted
2023-05-08 16:06:58
Documents
71
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20230331x10q.htm   iXBRL 10-Q 1182310
2 EX-10.1 ocul-20230331xex10d1.htm EX-10.1 709760
3 EX-31.1 ocul-20230331xex31d1.htm EX-31.1 12006
4 EX-31.2 ocul-20230331xex31d2.htm EX-31.2 8446
5 EX-32.1 ocul-20230331xex32d1.htm EX-32.1 4989
6 EX-32.2 ocul-20230331xex32d2.htm EX-32.2 4970
  Complete submission text file 0001558370-23-008510.txt   5793518

Data Files

Seq Description Document Type Size
7 EX-101.SCH ocul-20230331.xsd EX-101.SCH 38366
8 EX-101.CAL ocul-20230331_cal.xml EX-101.CAL 47465
9 EX-101.DEF ocul-20230331_def.xml EX-101.DEF 148686
10 EX-101.LAB ocul-20230331_lab.xml EX-101.LAB 274960
11 EX-101.PRE ocul-20230331_pre.xml EX-101.PRE 248954
65 EXTRACTED XBRL INSTANCE DOCUMENT ocul-20230331x10q_htm.xml XML 765172
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 23897748
SIC: 2834 Pharmaceutical Preparations